Home/Filings/4/0001437749-22-027849
4//SEC Filing

Patel Purav 4

Accession 0001437749-22-027849

CIK 0001742927other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 4:15 PM ET

Size

6.2 KB

Accession

0001437749-22-027849

Insider Transaction Report

Form 4
Period: 2022-11-18
Patel Purav
Director
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2022-11-18$4.69/sh+3,000$14,07043,547 total
Holdings
  • Common Stock, par value $0.0001 per share

    (indirect: By LLC)
    28,742
  • Common Stock, par value $0.0001 per share

    (indirect: By LLC)
    3,318
Footnotes (1)
  • [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Issuer

REVIVA PHARMACEUTICALS HOLDINGS, INC.

CIK 0001742927

Entity typeother

Related Parties

1
  • filerCIK 0001818246

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 4:15 PM ET
Size
6.2 KB